Insuman Rapid

Insulin Human, the active ingredient in Insuman Rapid, is an insulin presented as a solution for injection for subcutaneous use. It provides rapid‑acting glucose control for individuals with type 1 diabetes mellitus and type 2 diabetes mellitus, including both adult and pediatric patients requiring mealtime insulin therapy.

GNH USA supplies Insuman Rapid as a licensed, Good Distribution Practice‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring product quality and regulatory conformity across global markets with dedicated technical support and reliable logistics.

Insuman Rapid (insulin human) is used to manage blood glucose in the diabetes mellitus disease family. - Type 1 diabetes mellitus: provides rapid‑acting insulin to lower post‑prandial glucose levels. - Type 2 diabetes mellitus: offers mealtime insulin to improve glycemic control when oral agents are insufficient. - Gestational diabetes mellitus: may be prescribed when diet and oral therapy do not achieve target glucose, under medical supervision.

Insuman Rapid may be associated with a range of adverse reactions, varying in frequency and severity. Common Side Effects: - Hypoglycemia (low blood sugar) - Injection site pain or erythema - Lipodystrophy at injection sites - Weight gain - Allergic skin reactions (rash, itching) - Edema Serious or Rare Side Effects: - Severe hypoglycemia leading to loss of consciousness - Anaphylactic reaction or severe allergic response - Acute insulin allergy with systemic symptoms - Serum sickness‑like reaction - Persistent hyperglycemia due to insulin resistance - Unexplained cardiovascular events

When prescribing Insuman Rapid, clinicians should consider several precautionary measures to ensure safe use. - Dose adjustment: individualize dose based on blood glucose monitoring and carbohydrate intake. - Renal impairment: monitor closely and reduce dose if needed. - Hepatic impairment: use with caution due to altered insulin metabolism. - Pregnancy and lactation: assess risk‑benefit and adjust dosing under medical guidance. - Hypoglycemia risk: educate patients on recognizing and treating low blood glucose. - Storage: Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insuman Rapid can interact with several medicines that affect glucose metabolism or insulin action. Major Interactions (Avoid): - Beta‑blockers: may mask hypoglycemia symptoms. - MAO‑inhibitors: can potentiate insulin’s glucose‑lowering effect. - Corticosteroids: may cause marked hyperglycemia requiring dose increase. - Oral antidiabetic sulfonylureas: increase risk of severe hypoglycemia. - Alcohol: can cause unpredictable glucose fluctuations. Moderate Interactions (Monitor Closely): - ACE inhibitors: may enhance insulin sensitivity. - Thiazide diuretics: can raise blood glucose. - Antipsychotics (e.g., olanzapine): may increase insulin resistance. - Thyroid hormones: alter insulin requirements. - NSAIDs: may affect renal function impacting insulin clearance.